Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Journal of Geriatric Oncology|March 15, 2024
Older patients' experiences with and attitudes towards an oncogeriatric pathway: A qualitative studyAnna Uit den Boogaard, Dide de Jongh, Marjan J T van den Elst, et al.
BMC Health Services Research|November 18, 2020
Screening and patient-tailored care for emotional and cognitive problems compared to care as usual in patients discharged home after ischemic stroke (ECO-stroke): a protocol for a multicenter, patient-blinded, cluster randomized controlled trialJ P L Slenders, R M Van den Berg-Vos, C M van Heugten, et al.
Respiratory Medicine|September 21, 2020
The clinical effectiveness of the COPDnet integrated care modelE H Koolen, B van den Borst, M de Man, et al.
JCO Precision Oncology|July 21, 2022
<i>DPYD*7</i> as a Predictor of Severe Fluoropyrimidine-Related Adverse EventsMirjam de With, Gemma Brufau, Laila A van den Berg, et al.
Clinical Pharmacology and Therapeutics|December 21, 2018
Influence of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib: A Randomized Crossover Pharmacokinetic StudyFemke M de Man, Koen G A M Hussaarts, Mirjam de With, et al.
Acta Gastro-Enterologica Belgica|December 15, 2020
Current practice in approaching controversial diagnostic and therapeutic topics in gastroenteropancreatic neuroendocrine neoplasm management. Belgian multidisciplinary expert discussion based on a modified Delphi methodP-J Cuyle, K Geboes, S Carton, et al.
Frontiers in Pharmacology|December 3, 2021
Tissue Type Differences in ABCB1 Expression and Paclitaxel Tissue Pharmacokinetics in Patients With Esophageal CancerRuben A G van Eerden, Leni van Doorn, Femke M de Man, et al.
Journal of Psychosomatic Research|November 27, 2024
The factor structure of the Patient Health Questionnaire-9 in stroke: A comparison with a non-stroke populationJ J Blake, T Munyombwe, F Fischer, et al.
Clinical Pharmacology and Therapeutics|October 29, 2020
Effects of Protein and Calorie Restriction on the Metabolism and Toxicity Profile of Irinotecan in Cancer PatientsFemke M de Man, Ruben A G van Eerden, Gerdien M van Doorn, et al.
BMJ Open|December 11, 2019
Concomitant intraperitoneal and systemic chemotherapy for extensive peritoneal metastases of colorectal origin: protocol of the multicentre, open-label, phase I, dose-escalation INTERACT trialNadine Leonie de Boer, Alexandra R M Brandt-Kerkhof, Eva V E Madsen, et al.
Pageof 15